nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0389	0.0389	CcSEcCtD
Letrozole—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.0343	0.0343	CcSEcCtD
Letrozole—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0319	0.0319	CcSEcCtD
Letrozole—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0319	0.0319	CcSEcCtD
Letrozole—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.0305	0.0305	CcSEcCtD
Letrozole—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.0305	0.0305	CcSEcCtD
Letrozole—Cyst—Cyclosporine—focal segmental glomerulosclerosis	0.0277	0.0277	CcSEcCtD
Letrozole—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.0217	0.0217	CcSEcCtD
Letrozole—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0212	0.0212	CcSEcCtD
Letrozole—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.0211	CcSEcCtD
Letrozole—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0205	0.0205	CcSEcCtD
Letrozole—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.0195	CcSEcCtD
Letrozole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.0168	0.0168	CcSEcCtD
Letrozole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Letrozole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0143	CcSEcCtD
Letrozole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0143	CcSEcCtD
Letrozole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0138	CcSEcCtD
Letrozole—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0138	CcSEcCtD
Letrozole—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0137	CcSEcCtD
Letrozole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Letrozole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0122	CcSEcCtD
Letrozole—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Letrozole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0107	CcSEcCtD
Letrozole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.0106	0.0106	CcSEcCtD
Letrozole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0105	CcSEcCtD
Letrozole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0104	CcSEcCtD
Letrozole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0104	CcSEcCtD
Letrozole—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0103	CcSEcCtD
Letrozole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Letrozole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Letrozole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0101	CcSEcCtD
Letrozole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0101	CcSEcCtD
Letrozole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00981	0.00981	CcSEcCtD
Letrozole—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00936	0.00936	CcSEcCtD
Letrozole—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00931	0.00931	CcSEcCtD
Letrozole—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00931	0.00931	CcSEcCtD
Letrozole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00926	0.00926	CcSEcCtD
Letrozole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00919	0.00919	CcSEcCtD
Letrozole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00915	0.00915	CcSEcCtD
Letrozole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00913	0.00913	CcSEcCtD
Letrozole—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00864	0.00864	CcSEcCtD
Letrozole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00845	0.00845	CcSEcCtD
Letrozole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00839	0.00839	CcSEcCtD
Letrozole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00823	0.00823	CcSEcCtD
Letrozole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00816	0.00816	CcSEcCtD
Letrozole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0081	0.0081	CcSEcCtD
Letrozole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00795	0.00795	CcSEcCtD
Letrozole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00794	0.00794	CcSEcCtD
Letrozole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00787	0.00787	CcSEcCtD
Letrozole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00764	0.00764	CcSEcCtD
Letrozole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00752	0.00752	CcSEcCtD
Letrozole—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00741	0.00741	CcSEcCtD
Letrozole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00731	0.00731	CcSEcCtD
Letrozole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00728	0.00728	CcSEcCtD
Letrozole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00725	0.00725	CcSEcCtD
Letrozole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00707	0.00707	CcSEcCtD
Letrozole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.007	CcSEcCtD
Letrozole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0069	CcSEcCtD
Letrozole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0069	CcSEcCtD
Letrozole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0069	CcSEcCtD
Letrozole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.00688	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00685	0.00685	CcSEcCtD
Letrozole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.00682	CcSEcCtD
Letrozole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00675	0.00675	CcSEcCtD
Letrozole—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00661	0.00661	CcSEcCtD
Letrozole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00661	0.00661	CcSEcCtD
Letrozole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00657	0.00657	CcSEcCtD
Letrozole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00649	0.00649	CcSEcCtD
Letrozole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00642	0.00642	CcSEcCtD
Letrozole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.00639	CcSEcCtD
Letrozole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.00631	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00603	CcSEcCtD
Letrozole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00598	0.00598	CcSEcCtD
Letrozole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.00594	CcSEcCtD
Letrozole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0059	0.0059	CcSEcCtD
Letrozole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00588	CcSEcCtD
Letrozole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.00582	CcSEcCtD
Letrozole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.00575	CcSEcCtD
Letrozole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.00571	CcSEcCtD
Letrozole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.0057	CcSEcCtD
Letrozole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00566	0.00566	CcSEcCtD
Letrozole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00566	0.00566	CcSEcCtD
Letrozole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.00545	CcSEcCtD
Letrozole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.00541	CcSEcCtD
Letrozole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00525	CcSEcCtD
Letrozole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00523	CcSEcCtD
Letrozole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00523	CcSEcCtD
Letrozole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00475	0.00475	CcSEcCtD
Letrozole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.00468	CcSEcCtD
Letrozole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.00453	CcSEcCtD
Letrozole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00437	CcSEcCtD
Letrozole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.00421	CcSEcCtD
Letrozole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00417	CcSEcCtD
Letrozole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00417	CcSEcCtD
Letrozole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.00414	CcSEcCtD
Letrozole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00393	CcSEcCtD
